Showing results (81-90 of 320) with videos related to

Sort By:
Pageof 32
Molecular Cancer Therapeutics|March 3, 2011
A human model of epithelial to mesenchymal transition to monitor drug efficacy in hepatocellular carcinoma progressionFranziska van Zijl, Sabine Mall, Georg Machat, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|October 17, 2002
Expression of the lung resistance-related protein in human and rat hepatocarcinogenesisMaria Raidl, Walter Berger, Rolf Schulte-Hermann, et al.
Journal of Neuro-Oncology|July 20, 2002
Expression and functional activity of the ABC-transporter proteins P-glycoprotein and multidrug-resistance protein 1 in human brain tumor cells and astrocytesSabine Spiegl-Kreinecker, Johanna Buchroithner, Leonilla Elbling, et al.
Dalton Transactions (Cambridge, England : 2003)|October 30, 2013
Poly(lactic acid) nanoparticles of the lead anticancer ruthenium compound KP1019 and its surfactant-mediated activationBritta Fischer, Petra Heffeter, Kushtrim Kryeziu, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|April 9, 2008
Resistance against novel anticancer metal compounds: differences and similaritiesPetra Heffeter, Ute Jungwirth, Michael Jakupec, et al.
Neoplasia (New York, N.Y.)|June 22, 2005
Seven novel and stable translocations associated with oncogenic gene expression in malignant melanomaIchiro Okamoto, Christine Pirker, Martin Bilban, et al.
Chemistry & Biodiversity|October 20, 2012
Water-soluble cationic derivatives of indirubin, the active anticancer component from Indigo naturalisWerner Ginzinger, Alexander Egger, Gerhard Mühlgassner, et al.
Cancers|August 27, 2021
Thermodynamic Genome-Scale Metabolic Modeling of Metallodrug Resistance in Colorectal CancerHelena A Herrmann, Mate Rusz, Dina Baier, et al.
Cancer|March 7, 2012
Trabectedin has promising antineoplastic activity in high-grade meningiomaMatthias Preusser, Sabine Spiegl-Kreinecker, Daniela Lötsch, et al.
Pageof 32